Canada’s New Genetic Discrimination Law Will Prevent a ‘Gattaca’ Future
By Jordan Pearson,
VICE Motherboard
| 03. 09. 2017
But insurance companies say it's unconstitutional.
On Wednesday night, Canadian parliament bucked the Prime Minister to pass a law that makes it illegal for employers or insurance companies to discriminate against people based on their DNA.
A growing number of people are having their genomes sequenced so doctors can assess their risk for various diseases, such as breast or ovarian cancer. But insurance companies also want to get their hands on that information in order to determine who's most at risk of falling ill, and charge them accordingly. One could also imagine an employer wanting to know if an air traffic controller, for example, will risk a sudden heart attack.
However, being at higher risk of developing a certain disease is not a guarantee that'll actually happen. In the US, it's illegal to discriminate someone based on their genes, and now Canada's Genetic Non-Discrimination Act would offer similar protections, making it illegal for anyone to require genetic testing as a precondition for entering into a contract or providing goods and services.
This means that once the Governor General signs...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Robert Resta, The DNA Exchange | 07.22.2024
Medical geneticists and genetic counselors have an often complicated and at times tense relationship with people with disabilities, their families, advocates, and scholars. Geneticists are strong advocates and supporters for all of their patients, regardless of their abilities and disabilities...
By Katherine Bourzac, Nature | 07.10.2024
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...
